U.S. Life Sciences Stock News

Perella Weinberg Partners recently reported quarterly revenues of US$219.2 million, a 2.9% year-on-year decline that still exceeded analyst estimates by a very large margin, alongside an earnings beat. The results highlight how the firm’s operational execution outpaced expectations even as headline revenue slipped, offering a more nuanced picture of performance for investors. Next, we’ll examine how this better-than-expected revenue performance shapes Perella Weinberg Partners’ investment...

Community Trust Bancorp recently highlighted a quarterly dividend of US$0.53 per share, implying a 3.43% yield and reflecting five consecutive years of annual dividend increases averaging 5.32%. Alongside this dividend profile, the company is guided by a Zacks Consensus Estimate pointing to fiscal 2026 earnings of US$5.79 per share, suggesting investors are closely watching how income and earnings trends align. With this backdrop of consistent dividend growth, we’ll examine how the company’s...

In February 2026, STAAR Surgical announced that the FDA approved an expanded age indication for its EVO/EVO+ Visian Implantable Collamer Lenses, extending U.S. use from ages 21–45 to 21–60 following three-year safety data. This broader label meaningfully enlarges the potential U.S. candidate pool for EVO ICL, especially among adults aged 46–60 who were previously excluded. We’ll now examine how opening EVO ICL access to patients up to age 60 could reshape STAAR Surgical’s longer-term...

Coupang FY 2025 Results Set Up a Mixed but Margin Focused Story Coupang (CPNG) closed FY 2025 with fourth quarter revenue of US$8.8b and a basic EPS loss of US$0.01, as net income excluding extra items came in at a US$26m loss against a backdrop of growing full year scale. The company has seen quarterly revenue step up from US$7.9b in Q4 2024 to between US$7.9b and US$9.3b through 2025. Basic EPS has moved between a profit of US$0.06 and a small loss in the latest quarter, setting up a TTM...

If you are wondering whether Nova's share price still reflects good value after a strong run, this article is for you. We will walk through what the current market price might be implying about the business. Nova's stock last closed at US$438.86, with a 7 day return of a 0.5% decline, a 30 day return of a 9.9% decline, a year to date return of 26.3% and a 1 year return of 83.5%, while the 3 year return is very large and the 5 year return is also very large. Recent news coverage around Nova...

Opera (NasdaqGS:OPRA) posts FY 2025 results Opera (NasdaqGS:OPRA) closed out FY 2025 with fourth quarter revenue of US$176.7 million and basic EPS of US$0.62, rounding off a trailing twelve month run of US$614.4 million in revenue and EPS of US$1.21 as earnings grew 34.1% over the past year. The company has seen revenue move from US$480.6 million on a trailing basis at the end of 2024 to US$614.4 million by the end of 2025, while trailing net profit margin edged up from 16.8% to 17.6%. With...

Innodata (INOD) has just wrapped up FY 2025 with fourth quarter revenue of US$72.4 million and basic EPS of US$0.28, alongside trailing twelve month revenue of US$251.7 million and EPS of US$1.01. The company has seen quarterly revenue move from US$52.2 million in Q3 2024 to US$72.4 million in Q4 2025. Basic EPS has ranged from US$0.60 in Q3 2024 to between US$0.23 and US$0.28 across the 2025 quarters, setting up a picture where growing sales are rubbing against tighter margins and leaving...

On Holding (NYSE:ONON) is expanding rapidly across Asia-Pacific, adding new markets and strengthening its regional presence. The company is pushing its direct-to-consumer model globally, supported by its own performance footwear and apparel technology. Management is putting capital behind product development and customer engagement, with an eye on premium brand positioning worldwide. On Holding, trading at around $46.48, sits in a premium corner of the sportswear space with a 3 year return...

If you are wondering whether Prologis at around US$142.57 is priced for perfection or offering value, you are in the right place for a clear look at what the current share price might imply. The stock has recent returns of 0.7% over 7 days, 12.1% over 30 days, 10.5% year to date, 19.1% over 1 year, 23.5% over 3 years and 68.4% over 5 years. This naturally raises questions about how much optimism is already reflected in the price. Recent attention around Prologis has focused on its role as a...

Coterra Energy FY 2025 Earnings Snapshot Coterra Energy (CTRA) closed FY 2025 with fourth quarter revenue of US$1.8 billion and basic EPS of US$0.48, alongside net income excluding extra items of US$368 million, giving investors a clear read on its latest top and bottom line. Over the past year, the company has seen trailing twelve month revenue move from US$5.2 billion to US$7.3 billion, while trailing EPS shifted from US$1.51 to US$2.26 as net income excluding extra items moved from US$1.1...

Pinnacle West Capital (NYSE:PNW) entered a new $300 million revolving credit facility, replacing its prior arrangement. The facility extends through 2031 and is intended to support general corporate purposes and ongoing infrastructure investments. For investors watching NYSE:PNW, this fresh $300 million credit line arrives with the stock around $100.3 per share, alongside returns of 13.8% year to date and 63.9% over 5 years. These figures provide a snapshot of how the market has valued the...

If you are wondering whether 3M is still a solid value play at its current price, this article walks through what the numbers actually say about the stock. 3M shares last closed at US$165.32, with a 1% decline over the past week, a 6% gain over the last 30 days, and returns of 2.2% year to date, 8.5% over 1 year, a very large gain over 3 years, and 31% over 5 years. Recent headlines around 3M have focused on its ongoing business repositioning and legal overhangs, which continue to shape how...

In late February 2026, Globus Medical reported record Q4 2025 and full-year 2025 results, with sales rising to US$826.42 million for the quarter and US$2.94 billion for the year, and net income increasing to US$140.59 million and US$537.87 million respectively. Management reaffirmed 2026 revenue guidance of US$3.18 billion to US$3.22 billion while lifting non-GAAP EPS expectations and highlighting faster-than-planned benefits from the Nevro acquisition, underscoring how recent M&A and...

Perfect (PERF) has drawn fresh attention after partnering with True Beauty Lashes on LashLovr, an AI powered lash matching and virtual try on experience that highlights how its APIs are used in real retail journeys. See our latest analysis for Perfect. Even with the LashLovr partnership and recent earnings update, Perfect’s short term share price return has been weak, with a 30 day share price decline of 18.67% and a 1 year total shareholder return of 28.19% in the red. This points to fading...

Perrigo (NYSE:PRGO) has announced a new operational enhancement program after reporting significant progress on its Three-S transformation approach. The company highlighted a tripling in the value of its innovation pipeline and more than US$100 million in new distribution wins. Perrigo also reported a major net loss for the fourth quarter and full year, linked in part to an asset impairment charge. Management described 2026 as a transition year, citing manufacturing under-absorption, and is...

nLIGHT (LASR) has wrapped up FY 2025 with Q4 revenue of US$81.2 million and a basic EPS loss of US$0.10, alongside trailing twelve month revenue of US$261.3 million and a basic EPS loss of US$0.47. The company has seen quarterly revenue move from US$47.4 million in Q4 2024 to US$81.2 million in Q4 2025, while basic EPS over the same quarters shifted from a loss of US$0.51 to a loss of US$0.10. This leaves investors to weigh growth expectations against still negative margins and the path to...

National Health Investors (NHI) closed out FY 2025 with Q4 revenue of US$107.5 million and basic EPS of US$0.80, alongside funds from operations of US$58.5 million, which is a key earnings measure for healthcare REIT investors. The company reported quarterly revenue of US$85.8 million in Q4 2024 and US$107.5 million in Q4 2025, while basic EPS moved from US$0.96 to US$0.80 over the same period, providing a view of how the top line and earnings per share have developed into the latest release...

If you are wondering whether Philip Morris International (NYSE: PM) still offers value at around US$186.83 a share, you are not alone. This article is built to help you make sense of that question. The stock has returned 1.9% over the past week, 4.6% over the past month, 16.6% year to date and 24.6% over the past year, with a very large 3 year return and a very large 5 year return that many investors are trying to put into context. Recent headlines around Philip Morris International have...

Fresh off its Q2 2026 print, Zscaler (ZS) reported revenue of US$815.8 million and a basic EPS loss of US$0.21, with net income excluding extra items at a loss of US$34.3 million, setting the tone for how investors will read the quarter. The company has seen revenue move from US$647.9 million in Q2 2025 through to US$815.8 million in Q2 2026, while quarterly basic EPS over that stretch has ranged from a loss of US$0.05 in Q2 2025 to a loss of US$0.21 in the latest quarter. As a result, the...

FirstSun Capital Bancorp (NasdaqGS:FSUN) has received Office of the Comptroller of the Currency approval for its planned merger with First Foundation Inc. The merger remains subject to Federal Reserve approval and shareholder votes from both companies. If completed, the transaction is expected to significantly expand the combined bank's operations and product platform. FirstSun Capital Bancorp, a regional banking platform focused on commercial and consumer clients, is moving through a key...

Schrödinger, Inc. reported full-year 2025 results, with sales of US$56.37 million and total revenue of US$255.87 million, while reducing its net loss to US$103.27 million and basic loss per share from continuing operations to US$1.41. The combination of strong revenue growth and a substantially smaller loss suggests the company is scaling its platform while exercising tighter cost control. We’ll now examine how this sharp revenue increase and narrower loss shape Schrödinger’s existing...

If you are wondering whether Sociedad Química y Minera de Chile shares are still offering value at current levels, this article is here to unpack what the current price might be implying about the business. The stock last closed at US$76.30, with a 6.2% return over the past 7 days, a 9.4% return year to date, a 98.9% return over 1 year, a 71.6% return over 5 years and an 8.7% decline over 30 days. This can naturally raise questions about where expectations and risks now sit. Recent headlines...

What recent returns tell you about Arch Capital Group (ACGL) Arch Capital Group (ACGL) has drawn fresh attention after a steady run, with the stock showing gains over the past week, month, past 3 months, year to date, and the past year. Over longer stretches, its reported 3 year and 5 year total returns are also positive, which helps frame the current share price of $100.15 that investors are reacting to today. See our latest analysis for Arch Capital Group. For context, Arch Capital Group’s...

If you are wondering whether Parker-Hannifin's current share price still offers value, this article walks through what the numbers are saying about the stock today. The shares recently closed at US$1,009.18, with returns of 10.1% over the last 30 days, 12.9% year to date, and 52.4% over 1 year, while the 3 year and 5 year returns sit at 190.3% and 259.2% respectively. This follows a 1.3% decline over the past week. Recent coverage has focused on Parker-Hannifin as a large US capital goods...